Pietrangelo v. Sununu ( 2021 )


Menu:
  •             United States Court of Appeals
    For the First Circuit
    No. 21-1366
    JAMES E. PIETRANGELO, II,
    Plaintiff, Appellant,
    v.
    CHRISTOPHER SUNUNU, individually and in his official capacity as
    Governor of the State of New Hampshire, LISA MORRIS,
    individually and in her capacity as Director of NH Division of
    Public Health Services; LORI SHIBINETTE, individually and in her
    capacity as Commissioner of NH Department of Health and Human
    Services; ELIZABETH DALY, individually and in her capacity as
    Chief of NH Bureau of Infectious Disease Control
    Defendants, Appellees,
    UNKNOWN DOES, in their individual and official capacities,
    Defendants.
    APPEAL FROM THE UNITED STATES DISTRICT COURT
    FOR THE DISTRICT OF NEW HAMPSHIRE
    [Hon. Paul J. Barbadoro, U.S. District Judge]
    Before
    Lynch and Barron, Circuit Judges,
    and Burroughs,* District Judge.
    James E. Pietrangelo, II on brief pro se.
    Laura E. B. Lombardi, Senior Assistant Attorney General, and
    Samuel R. V. Garland, Assistant Attorney General, on brief for
    *   Of the District of Massachusetts, sitting by designation.
    appellees.
    October 1, 2021
    LYNCH, Circuit Judge.      In the early stages of COVID-19
    vaccine distribution, the State of New Hampshire implemented a
    plan to allocate its then-scarce supply.     Under the plan, at least
    ninety percent of the state's supply would be distributed in phases
    based on age, occupation, and medical risk.     The overall plan also
    earmarked up to ten percent of vaccines to an "equity plan" in
    order "to reach vulnerable individuals residing in census tracts
    identified as at risk of disproportionate impact from COVID-19."
    Pietrangelo v. Sununu, No. 21-cv-124-PB, 
    2021 WL 1254560
    , at *2
    (D.N.H. Apr. 5, 2021).     The factors the state used to designate
    census tracts as high risk included "minority status and language."
    New Hampshire residents who lived in those high-risk census tracts
    could qualify for an equity-plan vaccine by meeting one of ten
    criteria, including identifying as a racial or ethnic minority.
    Before he obtained a vaccine appointment, plaintiff
    James E. Pietrangelo, II     sued to challenge the equity plan.
    Pietrangelo, who is white and was then age fifty-five, argued that
    the plan illegally discriminated on the basis of race.       He sought
    a preliminary injunction, which the district court denied after
    concluding   Pietrangelo    failed    to   establish   a   substantial
    likelihood of standing.     Id. at *5.     Pietrangelo appealed from
    that denial of injunctive relief.    As we determine that his claims
    are moot, we dismiss this appeal.
    - 3 -
    "[A] case is moot when the issues presented are no longer
    'live' or the parties lack a legally cognizable interest in the
    outcome."    ACLU of Mass. v. U.S. Conf. of Cath. Bishops, 
    705 F.3d 44
    , 52 (1st Cir. 2013) (quoting D.H.L. Assocs., Inc. v. O'Gorman,
    
    199 F.3d 50
    , 54 (1st Cir. 1999)).          When we can no longer "give any
    'effectual relief' to the potentially prevailing party," we must
    dismiss   the    case.      
    Id.
       (quoting    Horizon     Bank    &     Tr.   Co.    v.
    Massachusetts, 
    391 F.3d 48
    , 53 (1st Cir. 2004)).                         Unless an
    exception to the doctrine applies, to do otherwise would be to
    render an advisory opinion, which Article III prohibits.                      See 
    id. at 52-53
    .
    By   the     time   the   district    court    denied       preliminary
    relief,   New    Hampshire      was   providing   vaccines       to     all   of    its
    residents older than sixteen.             And since then, the supply of
    vaccines available to New Hampshire, like the rest of the country,
    has skyrocketed.       As a result, vaccine scarcity is no longer the
    problem it once was.       Since early July, the demand for vaccines in
    New   Hampshire    has    plateaued.       See    State    of     New    Hampshire,
    Vaccination       Dashboard       (last    visited        Sept.       30,     2021),
    https://www.covid19.nh.gov/dashboard/vaccination.1 Vaccine supply
    1   While our review is generally limited to the record
    below, see Fed. R. App. P. 10, we may take judicial notice of facts
    which are "capable of being determined by an assuredly accurate
    source." United States v. Hoyts Cinemas Corp., 
    380 F.3d 558
    , 570
    (1st Cir. 2004); see Fed. R. Evid. 201(b)(2).      The accuracy of
    - 4 -
    in New Hampshire currently outstrips demand. See Ctrs. for Disease
    Control & Prevention, COVID Data Tracker: COVID-19 Vaccinations in
    the       United   States     (last   visited    Sept.   30,     2021),
    https://covid.cdc.gov/covid-data-tracker/#vaccinations         (showing
    in New Hampshire 1,750,221 doses administered and 2,142,860 doses
    delivered); 
    id.
     (showing seven-day average of 119 newly vaccinated
    individuals per day).       As for Pietrangelo, because he scheduled a
    vaccine appointment in April 2021, he no longer has any stake in
    how New Hampshire allocates its abundant supply of vaccines.        His
    claim for a preliminary injunction is thus moot.
    Pietrangelo's arguments to the contrary fail.     He argues
    that the state's "voluntary compliance" cannot moot the case, that
    he may need to receive a booster shot, that the equity plan
    increases his risk of contracting a breakthrough infection from an
    unvaccinated person,        and that, if moot, the case presents a
    question capable of repetition yet evading review.2      Starting with
    the voluntary compliance argument, the point is not that New
    Hampshire changed its actions but that a court can provide him
    with no relief.     Nor does Pietrangelo's speculation about booster
    state and federal vaccine distribution data cannot be reasonably
    questioned, and we take judicial notice of them.
    2   Pietrangelo also argues that his claims for declaratory
    relief and damages are still live.    Whether that contention is
    true, those claims are not before us in this interlocutory appeal
    from the denial of a preliminary injunction.
    - 5 -
    shots affect the mootness of his efforts to enjoin New Hampshire's
    plan to deal with limited vaccine supplies earlier this year.          As
    to   Pietrangelo's   concerns   about    non-vaccinated   New   Hampshire
    residents, the widespread availability of vaccines makes the risk
    based on the record before us far too insubstantial to qualify as
    a concrete injury.    See Equal Means Equal v. Ferriero, 
    3 F.4th 24
    ,
    29 (1st Cir. 2021).    Finally, this controversy is not capable of
    repetition yet evading review because we have no reason to think
    that New Hampshire will face a vaccine supply crunch in the future.
    See FEC v. Wis. Right to Life, Inc., 
    551 U.S. 449
    , 463 (2007).
    The appeal is dismissed.
    - 6 -